However, although COL1 expression showed a decreasing trend in the miR-450a-2-3p treatment group compared to the model group, the difference was not statistically significant (Fig. 5 J-M).
← all excerpts
miR-450a-2-3p targets ERK(1/2) to ameliorate ISO-induced cardiac fibrosis in mice.
1
—
—